Trastuzumab Active Not Recruiting Phase 3 Trials for HER2 Positive Breast Cancers Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Active Not Recruiting | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03013504 | A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients |